Photo of John Nutt, M.D.

John Nutt M.D.

Co-founder and Director Emeritus of the OHSU Parkinson Center and Movement Disorders Program

Dr. Nutt sees new patients in consultation only. If they wish to continue being seen at the center, he will recommend one of his colleagues to see them on a regular basis.

Dr. Nutt joined the OHSU movement disorders faculty in 1978 and is currently a professor of neurology. He is an expert clinician, scientist and teacher.

Dr. Nutt has gained international recognition for his innovative research in movement disorders and is widely used as a scientific consultant in the development of many new therapeutic agents for Parkinson's disease. He is widely recognized for his work on the pharmacokinetics of levodopa which has provided significant clinical and scientific insight on this important therapy for PD. His background in pharmacology has made him a world leader in testing many novel therapeutics for Parkinson's disease as well as new neuroprotective and neurorestorative therapies. He has also become a world leader and international expert in understanding the gait and balance problems of PD and ways to better manage these problems.

Dr. Nutt is an expert clinician for all movement disorders.

Read more

Education

  • M.D., Baylor College of Medicine, Houston Texas 0 1970
  • Residency:

    • Neurology - University of Washington, Seattle
  • Fellowship:

    • Clinical fellowship, Addiction Research Institute in Lexington, Kentucky, 1973

Publications

  • "Assessment of the ability of open- and closed-loop cueing to improve turning and freezing in people with Parkinson’s disease." Scientific Reports  In: , Vol. 8, No. 1, 12773, 01.12.2018.
  • "Gait stability has phase-dependent dual-task costs in Parkinson's disease." Frontiers in Neurology  In: , Vol. 9, No. MAY, 373, 30.05.2018.
  • "A wrinkle in ON-time - A GI structural abnormality confounding levodopa therapy with Duodopa rescue; a case study." Parkinsonism and Related Disorders  In: , Vol. 50, 01.05.2018, p. 130-131.
  • "Neurological disorders of gait, balance and posture : A sign-based approach." Nature Reviews Neurology  In: , Vol. 14, No. 3, 01.03.2018, p. 183-189.
  • "Case studies in neuroscience : a dissociation of balance and posture demonstrated by camptocormia." Journal of Neurophysiology  In: , Vol. 119, No. 1, 01.01.2018, p. 33-38.
  • "Apraxia of gait- or apraxia of postural transitions?" Parkinsonism and Related Disorders  In: , 01.01.2018.
  • "Investigation of anticipatory postural adjustments during One-Leg Stance using inertial sensors : Evidence from subjects with Parkinsonism." Frontiers in Neurology  In: , Vol. 8, No. JUL, 361, 25.07.2017.
  • "Dual task interference on postural sway, postural transitions and gait in people with Parkinson's disease and freezing of gait." Gait and Posture  In: , Vol. 56, 01.07.2017, p. 76-81.
  • "Impaired perception of surface tilt in progressive supranuclear palsy." PLoS One  In: , Vol. 12, No. 3, e0173351, 01.03.2017.
  • "The clinical significance of freezing while turning in Parkinson's disease." Neuroscience  In: , Vol. 343, 20.02.2017, p. 222-228.
  • "Recovery from multiple apas delays gait initiation in parkinson’s disease." Frontiers in Human Neuroscience  In: , Vol. 11, 60, 14.02.2017.
  • "Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease." Movement Disorders  In: , 2017.
  • "Quantifying effects of age on balance and gait with inertial sensors in community-dwelling healthy adults." Experimental Gerontology  In: , Vol. 85, 01.12.2016, p. 48-58.
  • "Objective gait and balance impairments relate to balance confidence and perceived mobility in people with parkinson disease." Physical Therapy  In: , Vol. 96, No. 11, 01.11.2016, p. 1734-1743.
  • "Pharmacological treatment in Parkinson's disease : Effects on gait." Parkinsonism and Related Disorders  In: , Vol. 31, 01.10.2016, p. 3-13.
  • "Balance and gait represent independent domains of mobility in Parkinson disease." Physical Therapy  In: , Vol. 96, No. 9, 01.09.2016, p. 1364-1371.
  • "Motor subtype in Parkinson's disease : Different disorders or different stages of disease?" Movement Disorders  In: , Vol. 31, No. 7, 01.07.2016, p. 957-961.
  • "Associations between mobility, cognition and callosal integrity in people with parkinsonism." NeuroImage: Clinical  In: , Vol. 11, 2016, p. 415-422.
  • "Effect of augmenting cholinergic function on gait and balance." BMC Neurology  In: , Vol. 15, No. 1, 264, 23.12.2015.
  • "Do cognitive measures and brain circuitry predict outcomes of exercise in Parkinson Disease : A randomized clinical trial." BMC Neurology  In: , Vol. 15, No. 1, 218, 24.10.2015.
  • "Effects of group, individual, and home exercise in persons with Parkinson disease : A randomized clinical trial." Journal of Neurologic Physical Therapy  In: , Vol. 39, No. 4, 01.10.2015, p. 204-212.
  • "Life-sustaining treatment orders, location of death and co-morbid conditions in decedents with Parkinson's disease." Parkinsonism and Related Disorders  In: , Vol. 21, No. 10, 2744, 01.10.2015, p. 1205-1209.
  • "Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's Disease." Movement Disorders  In: , Vol. 30, No. 10, 01.09.2015, p. 1361-1370.
  • "Continuous monitoring of turning in Parkinson's disease : Rehabilitation potential." NeuroRehabilitation  In: , Vol. 37, No. 1, 22.08.2015, p. 3-10.
  • "Freezing of gait : A practical approach to management." The Lancet Neurology  In: , Vol. 14, No. 7, 01.07.2015, p. 768-778.
  • "Dual-task interference and brain structural connectivity in people with Parkinson's disease who freeze." Journal of Neurology, Neurosurgery and Psychiatry  In: , Vol. 86, No. 7, 01.07.2015, p. 786-792.
  • "Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease : Comparisons of treatment at pallidal and subthalamic targets versus best medical therapy." Journal of Neurology, Neurosurgery and Psychiatry  In: , Vol. 86, No. 6, 01.06.2015, p. 622-629.
  • "Reply : Does dominant pedunculopontine nucleus exist? Probably not." Brain  In: , Vol. 138, No. 5, 01.05.2015, p. e347.
  • "Continuous levodopa infusion is better-for now." Movement Disorders  In: , Vol. 30, No. 4, 01.04.2015, p. 443-445.
  • "Preferences of Patients With Parkinson’s Disease for Communication About Advanced Care Planning." American Journal of Hospice and Palliative Medicine  In: , Vol. 32, No. 1, 19.02.2015, p. 68-77.

Additional information

Edit profile